Medicine Grand Rounds: Alzheimer's Biomarkers and Emerging Disease-Modifying Therapeutics 3/21/23

Medicine Grand Rounds: Alzheimer's Biomarkers and Emerging Disease-Modifying Therapeutics 3/21/23Подробнее

Duke Neurology Grand Rounds, July 19. 2023: Daniel Parker, MDПодробнее

Therapeutic Advances in the Early Treatment of Alzheimer’s DiseaseПодробнее

Medicine Grand Rounds: Challenges in Implementation of Colorectal Cancer Screening 3/28/23Подробнее

GR 10 14 2024 Disease Modifying Therapy in Alzheimer DiseaseПодробнее

Implications of Aducanumab, the New Alzheimer's Drug with Gil Rabinovici and Rita RedbergПодробнее

Grand Rounds 1 9 23: Dementia - A Neurologist's Approach by Christopher Kurahashi MDПодробнее

Preparing for Disease Modifying Therapies for DementiaПодробнее

Alzheimer’s Disease 2024: The Role of BiomarkersПодробнее

Biomarker Changes Preceding Alzheimer’s Disease | NEJMПодробнее

Duke Neurology Grand Rounds, March 16, 2022: Gwenn Garden, MDПодробнее

Duke Neurology Grand Rounds, March 23, 2022: Matthew Schrag, MD, PhDПодробнее

UCSF Psychiatry Grand Rounds: Delayed Recall Function in Alzheimer'sПодробнее

Grand Rounds - Dr Richard Isaacson 2/4/21Подробнее

Current & Emerging Treatments for Alzheimer's DiseaseПодробнее

Blood-based biomarkers: Supporting the diagnosis and treatment of Alzheimer’s diseaseПодробнее

UCSF Psychiatry Grand Rounds - Can We Manage the Dementia Epidemic?Подробнее

Infectious Diseases Grand Rounds - October 12, 2023Подробнее

Duke Neurology Grand Rounds, September 21, 2022: Andy Liu, MD, MSПодробнее

Alzheimer’s Epidemic: Disease-Modifying Therapies in Clinical Trials Offer Hope | Spotlight SeriesПодробнее